These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 23735830

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors.
    Ji H, Gómez-Vidal JA, Martasek P, Roman LJ, Silverman RB.
    J Med Chem; 2006 Oct 19; 49(21):6254-63. PubMed ID: 17034131
    [Abstract] [Full Text] [Related]

  • 26. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors.
    Ueda S, Terauchi H, Yano A, Matsumoto M, Kubo T, Kyoya Y, Suzuki K, Ido M, Kawasaki M.
    Bioorg Med Chem; 2004 Aug 01; 12(15):4101-16. PubMed ID: 15246088
    [Abstract] [Full Text] [Related]

  • 27. Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases.
    Maccallini C, Di Matteo M, Vullo D, Ammazzalorso A, Carradori S, De Filippis B, Fantacuzzi M, Giampietro L, Pandolfi A, Supuran CT, Amoroso R.
    ChemMedChem; 2016 Aug 19; 11(16):1695-9. PubMed ID: 27377568
    [Abstract] [Full Text] [Related]

  • 28. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors.
    Liu FZ, Fang H, Zhu HW, Wang Q, Yang Y, Xu WF.
    Bioorg Med Chem; 2008 Jan 01; 16(1):578-85. PubMed ID: 17937988
    [Abstract] [Full Text] [Related]

  • 29. Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity.
    Kang S, Tang W, Li H, Chreifi G, Martásek P, Roman LJ, Poulos TL, Silverman RB.
    J Med Chem; 2014 May 22; 57(10):4382-96. PubMed ID: 24758147
    [Abstract] [Full Text] [Related]

  • 30. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC, Sun J, Luo Y, Yang Y, Zhu HL.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4657-60. PubMed ID: 20594840
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Chiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitors.
    Jing Q, Li H, Chreifi G, Roman LJ, Martásek P, Poulos TL, Silverman RB.
    Bioorg Med Chem Lett; 2013 Oct 15; 23(20):5674-9. PubMed ID: 23993333
    [Abstract] [Full Text] [Related]

  • 36. Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase.
    Jackson SA, Sahni S, Lee L, Luo Y, Nieduzak TR, Liang G, Chiang Y, Collar N, Fink D, He W, Laoui A, Merrill J, Boffey R, Crackett P, Rees B, Wong M, Guilloteau JP, Mathieu M, Rebello SS.
    Bioorg Med Chem; 2005 Apr 15; 13(8):2723-39. PubMed ID: 15781384
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase.
    Castaño T, Encinas A, Pérez C, Castro A, Campillo NE, Gil C.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6193-206. PubMed ID: 18477512
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.